{"id":"c9bba9a9430e","type":"article","url":"https://hartvaat.nl/2026/02/01/is-er-een-nieuwe-keerzijde-van-persisterende-chylomicronemie/","title":"Is er een nieuwe keerzijde van persisterende chylomicronemie?","title_en":"Is there a new dark side of persistent chylomicronemia?","category":"cholesterol","category_label":"Cholesterol","professions":["cardioloog","internist"],"tags":["dyslipidemie","ezetimibe","familiaire-hypercholesterolemie-screening","vrouwen"],"journal":"Atherosclerosis","doi":"https://www.atherosclerosis-journal.com/article/S0021-9150(25)01524-2/fulltext","source_url":"https://doi.org/https://www.atherosclerosis-journal.com/article/S0021-9150(25)01524-2/fulltext","authors":["Philippe Moulin"],"significance":5,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/","https://hartvaat.nl/kennis/lipiden/dyslipidemie-overzicht/"],"congress":"","summary_en":"This commentary accompanies evidence suggesting that persistent severe hypertriglyceridaemia in familial and multifactorial chylomicronaemia syndromes may contribute to glomerular nephropathy, representing a previously unrecognised clinical complication.","created":"2026-07-03T10:25:29Z","updated":"2026-07-03T13:24:53Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Via cross-sectionele review van twee onafhankelijke cohorten van patiënten met familiaire of multifactoriële chylomicronemie onderzochten de auteurs of persisterende ernstige hypertriglyceridemie gepaard gaat met aanvullende klinische risico's.","abstract_original":"Through a cross-sectional review of two independent cohorts of patients with familial or multifactorial chylomicronemia syndrome (FCS or MCS) who were treated at two independent referral centers, the authors suggest that persistent and severe hypertriglyceridemia (sHTG) may be a contributing factor to the development of glomerular nephropathy [1]."}